No single SSRI is universally “the best.” All six SSRIs approved in the United States treat depression with roughly equal overall effectiveness, but they differ meaningfully in their side effects, how they interact with other medications, and how well they match specific symptoms or life circumstances. The right one for you depends on factors like your particular diagnosis, whether you’re dealing with fatigue or anxiety, what other medications you take, and how much you’re bothered by potential side effects like weight changes or sexual dysfunction.
Understanding these differences gives you a starting point for a more productive conversation with your prescriber, rather than simply accepting whatever gets written on the pad first.
The Six SSRIs and What They’re Approved For
The six SSRIs available in the U.S. are fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine (Luvox), citalopram (Celexa), and escitalopram (Lexapro). While all of them raise serotonin levels in the brain through the same basic mechanism, they each carry different FDA-approved uses beyond depression.
Sertraline has the broadest range of approved conditions: major depression, obsessive-compulsive disorder, panic disorder, PTSD, social anxiety disorder, and premenstrual dysphoric disorder. Fluoxetine is also widely approved, covering depression, OCD, panic disorder, and bulimia. Paroxetine covers depression, OCD, panic disorder, social anxiety, generalized anxiety, and PTSD. Escitalopram is approved for depression and generalized anxiety. Fluvoxamine is primarily approved for OCD. Citalopram is approved for depression.
This matters because if you’re dealing with something beyond depression, like panic attacks or PTSD, certain SSRIs have stronger evidence behind them for that specific condition. A prescriber will often lean toward a medication that covers multiple concerns at once rather than stacking separate treatments.
How They Differ in Side Effects
Side effects are often the deciding factor, since SSRIs work similarly for depression but feel quite different to live with day to day.
Sexual Side Effects
Sexual dysfunction is the most common complaint with SSRIs, affecting anywhere from 25% to 73% of people depending on the study and the specific drug. In one large comparison, paroxetine had the highest rate at about 71%, followed by citalopram at 73% in a separate study. Fluoxetine and sertraline fell in the mid-range, around 54% to 63%. These effects include reduced desire, difficulty reaching orgasm, and erectile difficulties. In one study comparing sertraline to bupropion (a non-SSRI antidepressant), 61% of men and 41% of women on sertraline reported problems with orgasm, compared to 10% and 7% on bupropion. If sexual side effects are a major concern for you, this is worth raising before starting treatment, since switching to a different class of antidepressant can make a significant difference.
Energy Level: Activating vs. Sedating
SSRIs aren’t all interchangeable when it comes to energy. Fluoxetine is the most “activating,” meaning it can increase alertness, restlessness, or even anxiety early in treatment. This can be helpful if your depression looks like extreme fatigue and low motivation, but it can backfire if you’re already anxious or having trouble sleeping. Paroxetine sits at the other end, being the most sedating SSRI. If anxiety and insomnia dominate your symptoms, paroxetine’s calming effect might work in your favor. The rest fall somewhere in between.
Weight Changes
Fluoxetine tends to cause short-term weight loss, making it a common choice when weight gain is a concern. Paroxetine, by contrast, is more associated with weight gain over time. Sertraline, citalopram, and escitalopram are generally considered more neutral, though individual responses vary.
How Long They Take to Work
All SSRIs take time. Mood improvements typically begin within the first one to two weeks, and these effects gradually build over six weeks or longer. The earliest changes are usually subtle, often noticed by people around you before you feel them yourself. Full therapeutic benefit generally takes eight to sixteen weeks. This timeline is roughly the same across all SSRIs, so if you’re choosing between them, speed of response isn’t a strong differentiator.
What does differ is how quickly your body adjusts to each one. Fluoxetine’s activating effects may cause early jitteriness that settles after a week or two. Paroxetine’s sedation is usually felt immediately. Most prescribers start at a low dose and increase gradually to minimize these adjustment side effects.
Drug Interactions and Half-Life
If you take other medications, this factor can narrow the field quickly. SSRIs are processed by liver enzymes, and some SSRIs block those same enzymes, causing other drugs to build up in your system.
Fluoxetine and paroxetine are the strongest blockers of CYP2D6, an enzyme that processes a wide range of medications including certain pain relievers, beta-blockers, and other psychiatric drugs. If you take any of these, fluoxetine or paroxetine could push their levels dangerously high. Sertraline is a moderate blocker of the same enzyme, posing less risk. Citalopram and escitalopram have the least impact on liver enzymes overall, making them the safest choices when drug interactions are a concern. Fluvoxamine, meanwhile, strongly blocks different enzymes (CYP1A2 and CYP2C19) and can interact with caffeine, certain blood thinners, and some antipsychotics.
Half-life also matters practically. Fluoxetine stays in your body far longer than any other SSRI, with the drug and its active breakdown product lingering for two to four weeks after you stop taking it. This makes it very forgiving if you miss a dose, but it also means side effects or interactions persist long after discontinuation. Sertraline and paroxetine have roughly 24-hour half-lives, clearing your system much faster. Paroxetine is notable because at higher doses, it inhibits its own metabolism, meaning its half-life gets longer the more you take.
Discontinuation Symptoms
Stopping an SSRI abruptly can cause withdrawal-like symptoms: dizziness, irritability, “brain zaps” (a strange electrical sensation in the head), nausea, and flu-like feelings. This is more of a problem with some SSRIs than others.
Paroxetine carries the highest risk of discontinuation symptoms because of its short half-life and the way it interacts with its own metabolism. Sertraline and fluvoxamine can also cause noticeable withdrawal if stopped suddenly. Fluoxetine, with its very long half-life, essentially tapers itself and rarely causes significant discontinuation problems. This is one reason prescribers sometimes switch patients to fluoxetine before stopping SSRI treatment altogether.
Choosing by Age and Life Stage
Older Adults
Guidelines recommend sertraline, escitalopram, or duloxetine (an SNRI, not an SSRI) as first-line choices for older adults. Paroxetine is generally avoided in this group because it has stronger anticholinergic effects, which can worsen confusion, dry mouth, constipation, and urinary retention. Fluoxetine’s activating properties and long half-life also make it less ideal for older patients.
Citalopram carries a specific cardiac concern. It’s the only SSRI that consistently prolongs the QTc interval, a measure of heart rhythm. The FDA restricts the maximum dose to 20 mg daily for people over 60. While the other SSRIs show some QTc changes in studies, citalopram’s effect is the most clinically significant, especially if you already have heart disease or take other medications that affect heart rhythm.
Pregnancy and Breastfeeding
All SSRIs cross the placenta and pass into breast milk. The overall risk of major birth defects from SSRIs is small or nonexistent based on current evidence, but paroxetine is the one exception to watch: it has been specifically linked to congenital heart defects and is generally avoided during pregnancy. Sertraline is often considered the preferred choice during pregnancy and breastfeeding because of its relatively low transfer into breast milk and its longer track record of use in this population. For mild to moderate depression during pregnancy, therapy without medication is typically tried first.
What Actually Drives the Decision
The American Academy of Family Physicians recommends that SSRI selection be based on four practical factors: your treatment history (what’s worked or failed before), other medical conditions you have, cost, and which side effects matter most to you. If a close family member responded well to a particular SSRI, you’re more likely to respond to the same one, since drug metabolism has a genetic component.
In practice, the decision often comes down to matching the drug’s personality to yours. If you’re exhausted and sluggish, fluoxetine’s activating profile may help. If you’re wired and anxious, paroxetine’s sedating qualities might be a better fit, though you’d want to weigh that against its higher risk of sexual side effects and discontinuation problems. If you take several other medications, escitalopram or citalopram (with the cardiac caveat) offer the cleanest interaction profile. If you have PTSD or PMDD alongside depression, sertraline covers the most ground with a single prescription.
Cost is worth mentioning: all six SSRIs are available as generics, so price differences are usually small. But insurance formularies can vary, and some generics are more widely stocked than others.
No algorithm perfectly predicts which SSRI will work best for any individual. About 40% to 60% of people respond well to the first antidepressant they try, and the rest need to switch or adjust. Knowing these differences ahead of time helps you ask better questions, set realistic expectations, and recognize when a switch might be worth discussing rather than assuming the medication simply “doesn’t work.”